论文部分内容阅读
目的了解医院重症监护病房(ICU)医院感染的分布及其影响因素,为采取有效干预措施提供参考。方法采用前瞻性监测方法,对某医院ICU住院患者医院感染情况进行监测,并对集束干预措施的效果进行观察。结果共监测该医院ICU入住危重症患者948例,监测到医院感染患者241例,医院感染发生率25.42%。该ICU使用呼吸机的患者呼吸机相关性肺炎(VAP)发生率平均为11.35%。通过集束干预措施,各年度医院感染率出现逐年下降趋势。该医院ICU感染患者送检标本中分离出的多重耐药菌居前5位的是鲍曼不动杆菌、铜绿假单胞菌、肺炎克雷伯菌、大肠埃希菌和耐甲氧西林金黄色葡萄球菌(MRSA)。结论该医院ICU住院患者医院感染发生率较高,经采取集束干预措施使得感染率呈现逐年下降趋势。
Objective To understand the distribution and influential factors of nosocomial infections in hospital intensive care unit (ICU) and provide reference for effective interventions. Methods The prospective monitoring method was used to monitor the hospital infection of inpatients in ICU of a hospital and the effect of cluster intervention was observed. Results A total of 948 critically ill patients admitted to ICU were monitored. 241 cases of nosocomial infections and 25.42% of nosocomial infections were detected. The average rate of ventilator-associated pneumonia (VAP) patients using the ventilator in this ICU was 11.35%. Through cluster interventions, the annual hospital infection rate showed a declining trend year by year. The top 5 multi-drug resistant isolates from the ICU-infected patients in the hospital were Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli and methicillin-resistant gold Staphylococcus aureus (MRSA). Conclusions The incidence of nosocomial infections in ICU patients in hospital is higher than that of nosocomial ICU patients.